ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
62,847.05
-1.40%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Akari Therapeutics PLC (AKTX)

  7. Akari Therapeutics PLC (AKTX) Noticias

AKTX Akari Therapeutics PLC

1.185
-0.005 (-0.42%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Akari Therapeutics PLC AKTX NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.005 -0.42% 1.185 16:16:11
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.19 1.17 1.20 1.185 1.19
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
15/3/202411:53PRNUSKuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to..
11/3/202416:25EDGAR2Form 425 - Prospectuses and communications, business..
11/3/202416:24EDGAR2Form 8-K - Current report
05/3/202415:57EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202407:34EDGAR2Form 425 - Prospectuses and communications, business..
05/3/202407:28EDGAR2Form 8-K - Current report
09/1/202416:25EDGAR2Form D - Notice of Exempt Offering of Securities
04/1/202411:34EDGAR2Form SC 13D/A - General statement of acquisition of..
02/1/202418:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202418:49EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202417:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202417:41EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202415:30EDGAR2Form 8-K - Current report
01/12/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/11/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202315:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/10/202316:00EDGAR2Form SC 13D/A - General statement of acquisition of..
20/10/202315:29EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202315:28EDGAR2Form POS AM - Post-Effective amendments for registration..
20/10/202315:23EDGAR2Form F-3 - Registration statement by foreign private issuers
12/10/202315:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202307:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/9/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/9/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/8/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/7/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/7/202307:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/7/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/7/202307:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/6/202315:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/5/202315:05GLOBEAspira Women’s Health Names Torsten Hombeck as Chief..

Su Consulta Reciente

NASDAQ
AKTX
Akari Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados